We are happy to invite you to the coming CCBIO course this fall: CCBIO905 – Methods in Cancer Biomarker Research, September 27-29, 2022, as a fully digital event in Zoom.
This course focuses on the full panel of standard and advanced methods with relevance for cancer biomarker research. The intention is to provide an understanding of the various methodologies and their application in basic and translational cancer research. The course further covers relevant topics like optimal sample collection and biobanking.
The thematic parts include methods ranging from basic techniques on nucleotides and proteins to more advanced approaches, as well as bioinformatics and biobanking. The course will focus on methods to study biomarkers in tissue samples, blood samples, circulating tumor cells and DNA, and other biologic materials. Methodologies like PCR techniques, microarray, next-generation sequencing, bioinformatics and artificial intelligence, immunohistochemistry, in situ hybridization, protein ligation assays, Western blot and ELISA, tissue microdissection and proteomics, flow cytometry, flow and imaging mass cytometry, and biobanking will be presented. Changes in nucleic acids and proteins in different settings will be discussed, as will the clinical applications.
Who: The course is open to researchers, postdocs, PhD students, master students, students enrolled in the Medical Student Research Program, and national and international students and researchers interested in the topic.
Place: Online on Zoom. Access links will be sent to the registered participants in due time.
When: September 27-29, 2022
Deadline/registration: August 1 for non-UiB students (reg. through Søknadsweb), and September 1 for UiB students (reg. through Studentweb) as well as for registration for non-ECTS participation.
Program: Preliminary program is available through this link.
Organizers: Lars A. Akslen and Agnete Engelsen have the academic responsibility, and Ingeborg Winge (ingeborg.winge@uib.no) is the course coordinator.
More information: on this website
Please feel free to share this information.
With best regards
Eli Synnøve Vidhammer
Communications
Centre for Cancer Biomarkers CCBIO